Posted on: March 11, 2013 by Mark Boslet
Alphabet Energy Inc. said it raised $16 million in Series B financing. The round was led by Encana Corp. and joined by existing investors Claremont Creek Ventures, TPG Biotech and the CalCEF Clean Energy Angel Fund. The funding allows the company to speed up product development and launch its first product, a device that generates electricity from the exhaust flows of engines in industrial applications.
Tags: Alphabet Energy, CalCEF Clean Energy Angel Fund, Claremont Creek Ventures, TPG Biotech
Posted on: June 6, 2012 by Jonathan Marino
Auxogyn, the women’s reproductive health company based in Menlo Park, California, just raised $18 million in a Series B round led by SR One. All of its Series A investors, including Kleiner Perkins Caufield and Byers, TPG Biotech and Merck Serono Ventures, participated in the funding. Simeon George, from SR One, and Nilesh Kumar, of [...]
Tags: Kleiner Perkins Caufield and Byers, Merck Serono, TPG Biotech
Posted on: April 19, 2012 by Jonathan Marino
Alder BioPharmaceuticals closed a $38 million Series D round led by a new investor—Novo Ventures—and including existing Alder investors Sevin Rosen Funds, Ventures West, WRF Capital, H.I.G. Ventures, Delphi Ventures and TPG Biotech. Novo’s Peter Bisgaard will join Alder’s board as part of the deal. Alder BioPharma is based in Washington and is develops products [...]
Tags: Delphi Ventures, H.I.G. Ventures, Novo Ventures, Sevin Rosen Funds, TPG Biotech, Ventures West, WRF Capital
Posted on: February 3, 2012 by asormani
Auxogyn, a privately-held company focused on advancing women’s reproductive health, has closed the final tranche of its Series A financing, bringing total funding to $20 million. Investors in the round include Kleiner Perkins Caufield and Byers, TPG Biotech and Merck Serono Ventures. PRESS RELEASE Auxogyn, Inc., a privately-held company focused on advancing women’s reproductive health, [...]
Tags: Kleiner Perkins Caufield and Byers, Merck Serono Ventures, TPG Biotech
Posted on: February 2, 2012 by cnolan
Auxogyn Inc., a Menlo Park, Calif. company focusing on products for women’s reproductive health, has closed a final tranche for its Series A round. The company has now raised $20 million in total funding. The initial tranche was placed in May 2010, and investors in the round include Kleiner Perkins Caufield and Byers, TPG Biotech and Merck Serono Ventures, the company said in a statement.
Tags: Kleiner Perkins Caufield and Byers, Merck Serono Ventures, TPG Biotech
Posted on: January 9, 2012 by asormani
Roka Bioscience has secured $47.5 million in Series D financing. New investor Aisling Capital participated in the financing along with existing investors OrbiMed Advisors, New Enterprise Associates and TPG Biotech. Josh Bilenker, MD, partner at Aisling Capital, will join Roka’s board of directors. Upon completion of theround, the total amount raised since the company’s formation [...]
Tags: New Enterprise Associates, OrbiMed Advisors, TPG Biotech
Posted on: January 4, 2012 by cnolan
Elevation Pharmaceuticals Inc. said Wednesday that it had closed $30 million in Series B financing led by new investor Novo Ventures. The company, which develops aerosol therapy for patients living with chronic obstructive pulmonary disease, was also backed in the round by previous investors including Canaan Partners, TPG Biotech, Care Capital and Mesa Verde Venture Partners. As part of the deal, Novo Ventures’ Heath Lukatch joins the company’s board. Elevation is based in San Diego, Calif.
Tags: Canaan Partners, Care Capital, Mesa Verde Venture Partners, Novo Ventures, TPG Biotech
Posted on: October 12, 2011 by cnolan
DNAnexus, a DNA data management and analysis platform, has closed a $15 million second round led by Google Ventures and TPG Biotech. First Round Capital, SoftTech VC, K9 Ventures, and Felicis Ventures also participated in the financing, which will be used for development. Krishna Yeshwant of Google Ventures, and Geoff Duyk of TPG Biotech, have joined the company’s board.
Tags: Felicis Ventures, First Round Capital, Google Ventures, K9 Ventures, SoftTech VC, TPG Biotech
Posted on: September 27, 2011 by asormani
San Diego-based Elevation Pharmaceuticals has drawn down a $17 million second tranche of its Series A financing. The biopharmaceutical company which develops new aerosol therapies for patients with respiratory diseases is celebrating positive results of a Phase 2a study and has initiated a Phase 2b study. All of the original participants in the Series A financing participated in the $17 million second tranche. These included Canaan Partners, Care Capital, TPG Biotech, and Mesa Verde Venture Partners.
Tags: Canaan Partners, Care Capital, Mesa Verde Venture Partners, TPG Biotech
Posted on: September 15, 2011 by PEHub Administrator
San Francisco-based Alphabet Energy, which develops thermoelectric materials (semiconductors) for waste-heat recovery, has landed a $12 million Series A led by TPG Biotech, with participation from existing investors Claremont Creek Ventures and the CalCEF Clean Energy Angel Fund. PRESS RELEASE: Alphabet Energy Inc., innovator of low-cost thermoelectric materials for waste-heat recovery, has closed $12 million in [...]
Tags: Alphabet Energy, CalCEF Clean Energy Angel Fund, Claremont Creek Ventures, TPG Biotech